PPJ Healthcare Enterprises, Inc.
PPJE · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | 26,528.16% | 153.35% | 142.30% | 357.54% |
| EV / EBITDA | 321.53 | 56.14 | 31.08 | 41.95 |
| Quality | ||||
| ROIC | 0.05% | 0.51% | 0.95% | 1.04% |
| Gross Margin | 15.56% | 30.39% | 38.06% | 43.13% |
| Cash Conversion Ratio | 301.42 | 33.89 | 21.40 | 98.10 |
| Growth | ||||
| Revenue 3-Year CAGR | -5.57% | 3.10% | 37.29% | 22.62% |
| Free Cash Flow Growth | -3.58% | -16.14% | -78.19% | 4.68% |
| Safety | ||||
| Net Debt / EBITDA | 320.40 | 34.04 | 16.04 | 14.98 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 138.76 | 55.61 | 14.92 | 7.92 |
| Cash Conversion Cycle | 1,236.68 | 1,212.76 | 1,313.88 | 1,338.01 |